Advertisement

MMW - Fortschritte der Medizin

, Volume 161, Issue 20, pp 62–65 | Cite as

Wie funktioniert sie und wann ist sie angebracht?

Opioidrotation bei Tumorschmerzen

  • Carmen RochEmail author
  • Birgitt von Oorschot
FORTBILDUNG . SEMINAR
  • 23 Downloads

Bei der Behandlung von Tumorschmerzen sind Opioide oft unverzichtbar. Was aber ist zu tun, wenn diese Substanzen nicht mehr ausreichend wirken oder zu unerträglichen Nebenwirkungen führen?

Opioid rotation in tumor pain therapy: useful?

Keywords

Opioidrotation opioidswitch tumor pain therapy 

Literatur

  1. 1.
    Graefe, K.-H., W. Lutz, and H. Bönisch, Tumorschmerzen, in Pharmakologie und Toxikologie: 201 Tabellen / Karl-Heinz Graefe; Werner Lutz; Heinz Bönisch. Unter Mitarb. von Johannes-Martin Hahn. 2011, Georg Thieme Verlag Stuttgart. p. 256.Google Scholar
  2. 2.
    Fine, P.G. and R.K. Portenoy, Establishing „best practices“ for opioid rotation: conclusions of an expert panel. J Pain Symptom Manage, 2009. 38(3): p. 418–25.CrossRefGoogle Scholar
  3. 3.
    Quigley, C., Opioid switching to improve pain relief and drug tolerability. Cochrane Database Syst Rev, 2004(3): p. Cd004847.Google Scholar
  4. 4.
    Dale, O., K. Moksnes, and S. Kaasa, European Palliative Care Research Collaborative pain guidelines: Opioid switching to improve analgesia or reduce side effects. A systematic review. Palliative Medicine, 2011. 25(5): p. 494–503.CrossRefGoogle Scholar
  5. 5.
    Mercadante, S. and R.K. Portenoy, Opioid poorly-responsive cancer pain. Part 1: clinical considerations. J Pain Symptom Manage, 2001. 21(2): p. 144–50.CrossRefGoogle Scholar
  6. 6.
    Khademi, H., et al., Opioid Therapy and its Side Effects: A Review. Arch Iran Med, 2016. 19(12): p. 870–876.PubMedGoogle Scholar
  7. 7.
    Caraceni, A., et al., Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol, 2012. 13(2): p. e58–68.CrossRefGoogle Scholar
  8. 8.
    S3-Leitlinie Palliativmedizin, L. Onkologie, Editor. Mai 2015.Google Scholar
  9. 9.
    Mercadante, S. and R.K. Portenoy, Opioid poorly-responsive cancer pain. Part 3. Clinical strategies to improve opioid responsiveness. J Pain Symptom Manage, 2001. 21(4): p. 338–54.CrossRefGoogle Scholar
  10. 10.
    Baines, M.J., Symptom control in advanced gastrointestinal cancer. Eur J Gastroenterol Hepatol, 2000. 12(4): p. 375–9.CrossRefGoogle Scholar
  11. 11.
    Bechakra, M., et al., Opioid responsiveness of nociceptive versus mixed pain in clinical cancer patients. Eur J Cancer, 2018. 105: p. 79–87.CrossRefGoogle Scholar
  12. 12.
    Nersesyan, H. and K.V. Slavin, Current aproach to cancer pain management: Availability and implications of different treatment options. Ther Clin Risk Manag, 2007. 3(3): p. 381–400.PubMedPubMedCentralGoogle Scholar
  13. 13.
    Cahill, C.M., et al., Allostatic Mechanisms of Opioid Tolerance Beyond Desensitization and Downregulation. Trends Pharmacol Sci, 2016. 37(11): p. 963–976.CrossRefGoogle Scholar
  14. 14.
    Farmer, A.D., et al., Pathophysiology, diagnosis, and management of opioid-induced constipation. Lancet Gastroenterol Hepatol, 2018. 3(3): p. 203–212.CrossRefGoogle Scholar
  15. 15.
    Eisenberg, E., E. Suzan, and D. Pud, Opioid-induced hyperalgesia (OIH): a real clinical problem or just an experimental phenomenon? J Pain Symptom Manage, 2015. 49(3): p. 632–6.CrossRefGoogle Scholar
  16. 16.
    Schuster, M., et al., Opioid Rotation in Cancer Pain Treatment. Dtsch Arztebl Int, 2018. 115(9): p. 135–142.PubMedPubMedCentralGoogle Scholar
  17. 17.
    Knotkova, H., P.G. Fine, and R.K. Portenoy, Opioid rotation: the science and the limitations of the equianalgesic dose table. J Pain Symptom Manage, 2009. 38(3): p. 426–39.CrossRefGoogle Scholar

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2019

Authors and Affiliations

  1. 1.Interdisziplinäres Zentrum PalliativmedizinUniversitätsklinikum WürzburgWürzburgDeutschland
  2. 2.

Personalised recommendations